LivaNova (Nasdaq: LIVN) today announced its new strategic roadmap and long-range financial plan at its 2025 Investor Day.
The age of onset of narcolepsy ranges from childhood to the fourth decade of life, with onset after 50s being rare. Onset at an advanced age is one of the factors involved in the delay in diagnosis.
This application is based on the encouraging results from the Phase 3 registration clinical study GLORY-2 (NCT06164873) of mazdutide 9 mg in Chinese adults with moderate to severe obesity. The study ...
Why Am I Not Losing Weight on Wegovy®? How to Get Results Key takeaways: Not losing weight on Wegovy® could be due to dose, ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Investor's Business Daily on MSN
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the party over?
A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP ...
Early treatment of obstructive sleep apnea may decrease the risk of Parkinson's disease, a new study published Monday finds.
Untreated sleep apnea may nearly double the chances of developing Parkinson’s disease, but CPAP therapy sharply reduces that risk.
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback